Paper11699883
Recent advances in the formation of the bacterial peptidoglycan monomer unit.
van Heijenoort J. Nat Prod Rep, 2001. Cited by 335 papers, by iCite.
Cite this record
ConductScience Library. Recent advances in the formation of the bacterial peptidoglycan monomer unit. Papers, record 11699883. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/11699883
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Bacteria | Major topic |
| Peptidoglycan | Major topic |
| Alanine | |
| Catalysis | |
| Glutamic Acid | |
| Intramolecular Transferases | |
| Ligases | |
| Molecular Structure | |
| Oxidoreductases | |
| Peptide Synthases | |
| Peptides | |
| Transferases | |
| Uridine Diphosphate N-Acetylmuramic Acid |
Source PubMed
Cited by131
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 335 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41427669 | Identification and characterization of RacX, a new broad-specificity amino acid racemase from a novel taxon within the order Flavobacteriales. | Appl Environ Microbiol | 2026 | https://conductscience.org/library/papers/41427669 | PubMed |
| 41134566 | Lipid II unlocked: strategies for obtaining a major antibiotic target. | Chem Commun (Camb) | 2025 | https://conductscience.org/library/papers/41134566 | PubMed |
| 40977139 | Tyrosine kinase Cps2C regulates the synthesis of capsular polysaccharides and plays a role in the virulence of Streptococcus suis serotype 2. | Virulence | 2025 | https://conductscience.org/library/papers/40977139 | PubMed |
| 40719242 | Dual Isotopologue Profiling of Bacterial Pathogens and their Host Cells: Metabolic Adaptation of Human Macrophages and Fallopian Tube Cells to Intracellular Chlamydia trachomatis. | ACS Chem Biol | 2025 | https://conductscience.org/library/papers/40719242 | PubMed |
| 40647152 | Revealing the Response Mechanism of Pediococcus pentosaceus Under Acid and Alcohol Stresses via a Combined Transcriptomic and Metabolomic Analysis. | Foods | 2025 | https://conductscience.org/library/papers/40647152 | PubMed |
| 40481781 | Elucidating Energy Conversion Pathways at Biotic/Abiotic Interfaces in Microbe-Semiconductor Hybrids. | J Am Chem Soc | 2025 | https://conductscience.org/library/papers/40481781 | PubMed |
| 40106796 | Revision of the Formycin A and Pyrazofurin Biosynthetic Pathways Reveals Specificity for d-Glutamic Acid and a Cryptic N-Acylation Step During Pyrazole Core Formation. | J Am Chem Soc | 2025 | https://conductscience.org/library/papers/40106796 | PubMed |
| 39578460 | Quinolone-mediated metabolic cross-feeding develops aluminium tolerance in soil microbial consortia. | Nat Commun | 2024 | https://conductscience.org/library/papers/39578460 | PubMed |
| 39225221 | Promising New Targets for the Treatment of Infections Caused by Acinetobacter baumannii: A Review. | Curr Drug Targets | 2024 | https://conductscience.org/library/papers/39225221 | PubMed |
| 38200161 | Identification of a new oligomycin derivative as a specific inhibitor of the alternative peptidoglycan biosynthetic pathway. | J Antibiot (Tokyo) | 2024 | https://conductscience.org/library/papers/38200161 | PubMed |
| 38138566 | Antibiotics and Antibiotic Resistance-Mur Ligases as an Antibacterial Target. | Molecules | 2023 | https://conductscience.org/library/papers/38138566 | PubMed |
| 37929742 | Docking of T6361 Analogues as Potential Inhibitors of E.coli MurA Followed by ADME-Toxicity Study. | Curr Drug Discov Technol | 2024 | https://conductscience.org/library/papers/37929742 | PubMed |
| 37692019 | Probing antibacterial drugs for Fusobacterium nucleatum subsp. nucleatum ATCC 25586 targeting UDP-N-acetylglucosamine 1-carboxyltransferase. | J Adv Pharm Technol Res | 2023 | https://conductscience.org/library/papers/37692019 | PubMed |
| 37540745 | Killing of Staphylococcus aureus persisters by a multitarget natural product chrysomycin A. | Sci Adv | 2023 | https://conductscience.org/library/papers/37540745 | PubMed |
| 36909155 | Antibacterial sensitizers from natural plants: A powerful weapon against methicillin-resistant Staphylococcus aureus. | Front Pharmacol | 2023 | https://conductscience.org/library/papers/36909155 | PubMed |
| 36690779 | Novel D-glutamate catabolic pathway in marine Proteobacteria and halophilic archaea. | ISME J | 2023 | https://conductscience.org/library/papers/36690779 | PubMed |
| 35967276 | Overcoming Mycobacterium tuberculosis through small molecule inhibitors to break down cell wall synthesis. | Acta Pharm Sin B | 2022 | https://conductscience.org/library/papers/35967276 | PubMed |
| 35802586 | Identifying potential biomarkers and therapeutic targets for dogs with sepsis using metabolomics and lipidomics analyses. | PLoS One | 2022 | https://conductscience.org/library/papers/35802586 | PubMed |
| 35648451 | Efficient extracellular production of recombinant proteins in E. coli via enhancing expression of dacA on the genome. | J Ind Microbiol Biotechnol | 2022 | https://conductscience.org/library/papers/35648451 | PubMed |
| 35617397 | Bioinformatic prospecting and synthesis of a bifunctional lipopeptide antibiotic that evades resistance. | Science | 2022 | https://conductscience.org/library/papers/35617397 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/11699883
GET https://conductscience.org/api/papers/v1/11699883/cited_by?page=2